Skip to main content
Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
8.23
+0.20 (2.49%)
At close: Apr 28, 2026, 4:00 PM EDT
8.23
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:30 PM EDT

Emergent BioSolutions Revenue

In the year 2025, Emergent BioSolutions had annual revenue of $742.90M, down -28.81%. Emergent BioSolutions had revenue of $148.70M in the quarter ending December 31, 2025, a decrease of -23.63%.

Revenue (ttm)
$742.90M
Revenue Growth
-28.81%
P/S Ratio
0.57
Revenue / Employee
$825,444
Employees
900
Market Cap
425.03M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025742.90M-300.70M-28.81%
Dec 31, 20241.04B-5.70M-0.54%
Dec 31, 20231.05B-68.20M-6.10%
Dec 31, 20221.12B-656.10M-36.99%
Dec 31, 20211.77B196.30M12.45%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Organogenesis Holdings 564.17M
Esperion Therapeutics 403.14M
Evolus 297.18M
Ironwood Pharmaceuticals 296.15M
Akebia Therapeutics 236.20M
Canopy Growth 203.04M
Kamada 180.46M
SIGA Technologies 94.57M
Revenue Rankings

EBS News

More News